Vitrolife takes over sales and marketing management of fertility media in UK and Ireland

Vitrolife (STO:VITR) is taking over management of marketing and sales of fertility media in UK and Ireland. “The acquisition is in line with Vitrolife’s strategy to operate using our own personnel and our own management in the most important markets,” says Magnus Nilsson, Vitrolife’s CEO.

IVF Ltd has been responsible since 2002 for sales and distribution of Vitrolife’s fertility media in UK and Ireland, while sales of instrument products, such as needles and pipettes, have been made under Vitrolife’s own management.

In UK an estimated 50,000 IVF cycles are performed each year where Vitrolife’s products are relevant. The market potential for Vitrolife’s product range in UK corresponds to SEK 85-100 million.

“As from November 2, 2009 Vitrolife will be able to offer our customers an almost complete range of products and service by supplying both culture media and instruments for IVF treatment direct from us. Vitrolife would like to thank IVF Ltd and its personnel for the years of successful and dedicated work that they have put into sales of and customer support for our products in UK and Ireland,” says Nils Sellbom, Vitrolife’s Marketing and Sales Director.

In connection with the takeover, IVF Ltd will change name to Vitrolife Ltd.